Dr. Macdonald joined Controlled Therapeutics (Scotland) as Managing Director in 2007 and became Executive Vice President of CPSI in 2009. He earned a degree in biochemistry with first class honors from Strathclyde University. He later received his doctorate from the Department of Materia Medica at the University of Glasgow. Dr. Macdonald has had a distinguished career in the pharmaceutical industry in positions such as Executive Director, Marketing and Sales, for Hoechst-Roussel and Chief Executive Officer of PanTherix. Before joining Controlled Therapeutics and CPSI, he was Chief Executive Officer of Scottish Health Innovations Ltd., a newly formed company established to capture and exploit technology from the National Health Service.

Dr. Powers joined Cytokine PharmaSciences, Inc. in February 2004, as Vice President of Clinical Development. She brings a wealth of international experience in both the healthcare and pharmaceutical industries to the company. Dr. Powers began her career as an obstetrical nurse, spending 9 years working in labor & delivery, followed by 3 years as a pediatric nursing instructor. Her career in the pharmaceutical industry began with a move to Rorer Group in 1986. When Rorer merged with the French company, Rhône-Poulenc, in 1991, Dr. Powers was given the opportunity to expand her operational abilities beyond the US. During her 14 years at Rorer and Rhône-Poulenc Rorer (now Sanofi Aventis), she held positions of increasing responsibility, leaving there as Assistant Director of Clinical Operations with worldwide responsibility for CRA operations in 6 therapeutic areas. After leaving Sanofi Aventis, Dr. Powers worked as an employee or consultant head of clinical development for several start-up and biotechnology companies, including Neuron Therapeutics, Neuronyx, Seacoast Technologies, and Palatin Technologies.